Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive content changes to the study details or page functionality were observed.
    Difference
    0.0%
    Check dated 2026-01-14T01:24:11.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Results have been posted for NCT04269200, with enrollment updated to 805 and 202 locations (including Erlangen, Germany). The page now lists a broad set of outcome measures (PFS, OS, PFS2, ORR, DoR, TFST, TSST, TDT, PK, ADA, and HRQoL) along with their assessment schedules.
    Difference
    1%
    Check dated 2025-12-30T13:25:22.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Locations for many US states and Canadian provinces were added and removed, and a Revision: v3.3.3 appears, signaling an update to the listing of study sites.
    Difference
    1%
    Check dated 2025-12-23T09:25:16.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-12-01T17:45:31.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a note that PubMed-derived publications are automatically filled for the study page and may not be about the study, and updated the revision to v3.3.1; removed the previous PubMed note and Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T14:49:40.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Deleted the generic government operating status notice from the page, which does not affect the study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-17T07:34:14.000Z thumbnail image

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.